NIIMBL is pleased to share this Request for Information (RFI) on filtration solutions for mRNA-LNP drug products.
The goal of this RFI is to gather insights and ideas regarding innovative approaches, current practices, and validation strategies for sterile filtration of lipid nanoparticle (LNP)-based products, including mRNA therapeutics.
Please review the full RFI document for more background information and requirements.
The submission deadline is October 1, 2025 (5 pm ET).
August 12, 2025 | RFI Release |
October 1, 2025 | Submission Deadline |
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.